DOCSLIB.ORG

Α-Dystrobrevin-1 Recruits Α-Catulin to the Α1d- Adrenergic Receptor/Dystrophin-Associated Protein Complex Signalosome

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Α-Dystrobrevin-1 Recruits Α-Catulin to the Α1d- Adrenergic Receptor/Dystrophin-Associated Protein Complex Signalosome α-Dystrobrevin-1 recruits α-catulin to the α1D- adrenergic receptor/dystrophin-associated protein complex signalosome John S. Lyssanda, Jennifer L. Whitingb, Kyung-Soon Leea, Ryan Kastla, Jennifer L. Wackera, Michael R. Bruchasa, Mayumi Miyatakea, Lorene K. Langebergb, Charles Chavkina, John D. Scottb, Richard G. Gardnera, Marvin E. Adamsc, and Chris Haguea,1 Departments of aPharmacology and cPhysiology and Biophysics, University of Washington, Seattle, WA 98195; and bDepartment of Pharmacology, Howard Hughes Medical Institute, University of Washington, Seattle, WA 98195 Edited by Robert J. Lefkowitz, Duke University Medical Center/Howard Hughes Medical Institute, Durham, NC, and approved October 29, 2010 (received for review July 22, 2010) α1D-Adrenergic receptors (ARs) are key regulators of cardiovascu- pression increases in patients with benign prostatic hypertrophy lar system function that increase blood pressure and promote vas- (12). Through proteomic screening, we discovered that α1D-ARs cular remodeling. Unfortunately, little information exists about are scaffolded to the dystrophin-associated protein complex the signaling pathways used by this important G protein-coupled (DAPC) via the anchoring protein syntrophin (10). Coexpression α “ α receptor (GPCR). We recently discovered that 1D-ARs form a sig- with syntrophins increases 1D-AR plasma membrane expression, nalosome” with multiple members of the dystrophin-associated drug binding, and activation of Gαq/11 signaling after agonist protein complex (DAPC) to become functionally expressed at the activation. Moreover, syntrophin knockout mice lose α1D-AR– plasma membrane and bind ligands. However, the molecular stimulated increases in blood pressure, demonstrating the im- α α mechanism by which the DAPC imparts functionality to the 1D- portance of these essential GIPs for 1D-AR function in vivo (10). AR signalosome remains a mystery. To test the hypothesis that Proper organization of signaling molecules within cells by the previously unidentified molecules are recruited to the α1D-AR sig- DAPC is essential for the maintenance of cellular homeostasis at nalosome, we performed an extensive proteomic analysis on each synaptic junctions (13). Mutations in DAPC result in severe PHARMACOLOGY member of the DAPC. Bioinformatic analysis of our proteomic data muscle wasting diseases, such as Duchenne muscular dystrophy/ sets detected a common interacting protein of relatively unknown Becker muscular dystrophy, and as a result, the role of this function, α-catulin. Coimmunoprecipitation and blot overlay complex for proper skeletal muscle function has been thoroughly assays indicate that α-catulin is directly recruited to the α1D-AR studied (14). However, the DAPC performs many other func- signalosome by the C-terminal domain of α-dystrobrevin-1 and tions: it facilitates proper water transport across the blood–brain not the closely related splice variant α-dystrobrevin-2. Proteomic barrier by anchoring aquaporin (15, 16), clusters nicotinic ace- and biochemical analysis revealed that α-catulin supersensitizes tylcholine receptors to ensure signal transmission at para- α1D-AR functional responses by recruiting effector molecules to sympathetic synapses (13), and anchors neuronal NOS at the cell the signalosome. Taken together, our study implicates α-catulin membrane in cardiac myocytes to permit cardiodilation (17). We as a unique regulator of GPCR signaling and represents a unique previously demonstrated that α1D-ARs form a complex with the expansion of the intricate and continually evolving array of GPCR DAPC (10), but why this interaction is necessary for α1D-AR signaling networks. functional coupling is unknown. In this study, we postulated that molecules necessary for α protein-coupled receptors (GPCRs) are seven-transmembrane 1D-AR signaling are recruited by the DAPC. Using a sequential fi α spanning proteins that are responsible for communicating in- proteomic screening approach, we identi ed -catulin as a G α formation in the form of extracellular stimuli across lipid mem- unique member of the 1D-AR signalosome. The goal of these α branes into distinct intracellular signals with precise accuracy. After experiments was to understand how -catulin integrates into this ligand binding, GPCRs signal through the canonical heterotrimeric growing GPCR protein complex and to decipher the purpose of G protein signaling pathway to activate a diverse array of down- this relatively unstudied protein in GPCR signaling networks. stream effectors (1). Recently, it has become evident that most Results GPCRs collaborate with one or more additional proteins at specific α α points in their lifecycle. These GPCR interacting proteins (or GIPs) -Catulin: Unique Member of the 1D-AR/DAPC Signalosome. We α are largely receptor subtype and cell context specific, include both previously demonstrated that syntrophins are required for 1D- α membrane and cytosolic proteins, and typically play a highly specific AR function in vitro and in vivo by anchoring 1D-ARs to the fi DAPC (10). Our working hypothesis is that the DAPC facilitates supporting role for GPCR function (i.e., traf cking, ligand binding, α enhancing signaling, signal termination, and/or degradation) (2–4). 1D-AR function by acting as a multiprotein scaffold to arrange Recently, we used yeast two-hybrid and proteomic screens to signaling molecules in close proximity to the receptor. To test this hypothesis, we fused tandem-affinity purification (TAP) epitopes identify GIPs for a clinically important GPCR, the α1D-adrenergic receptor (AR) (5). A member of the adrenergic family (α1, α2, β), α1D-ARs are ubiquitously expressed on blood vessels and are responsible for increasing blood pressure during exercise, injury, Author contributions: J.S.L., J.L. Whiting, J.L. Wacker, M.R.B., M.M., L.K.L., C.C., J.D.S., R.G.G., α M.E.A., and C.H. designed research; J.S.L., J.L. Whiting, K.-S.L., R.K., M.R.B., M.M., L.K.L., stress, or cardiovascular disease (6). 1D-AR knockout mice are M.E.A., and C.H. performed research; J.S.L., J.L. Whiting, J.L. Wacker, M.R.B., C.C., J.D.S., hypotensive and resistant to high salt diet-induced hypertension R.G.G., M.E.A., and C.H. analyzed data; and J.S.L., J.D.S., R.G.G., M.E.A., and C.H. wrote the (7, 8), yet this GPCR has been largely ignored over the past 20 y paper. fl because after transfection into cell culture α1D-ARs are seques- The authors declare no con ict of interest. tered in the endoplasmic reticulum (9, 10). Clinical interest in This article is a PNAS Direct Submission. the α1D-AR as a drug target has recently increased with the dis- 1To whom correspondence should be addressed. E-mail: [email protected]. α coveries that 1D-ARs are the predominant subtype expressed in This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. epicardial coronary arteries (11) and that α1D-AR prostate ex- 1073/pnas.1010819107/-/DCSupplemental. www.pnas.org/cgi/doi/10.1073/pnas.1010819107 PNAS Early Edition | 1of6 Downloaded by guest on September 29, 2021 α α α containing streptavidin/calmodulin-binding proteins to the α1D- -Catulin Is Recruited to the 1D-AR Signalosome by -DB1. We α α α β β AR and all members of the DAPC, including, α-syntrophin, β - detected -catulin as a positive interactor in the 1D-AR, / 1/ 2- 1 α fi syntrophin, β -syntrophin, α-dystrobrevin-1 (α-DB1), and α-DB2. syntrophin, and -DB1 proteomic screens, making it dif cult to 2 α HEK293 cell lines stably expressing each individual clone were predict which protein directly binds and recruits -catulin to the α created. TAP-tagged and associated proteins were purified from 1D-AR/DAPC signalosome. An important clue was that α-catulin was not detectable in the α-DB2 screen (Fig. 1A and lysates of each stable cell line, digested with trypsin, and the Table S1). α-DB1 and α-DB2 are C-terminal splice variants of tryptic peptides subjected to liquid chromatography (LC) tandem the α-DB gene (20). Following their common 504-aa core, mass spectrometry (MS/MS). α-DB1 has a unique 184-aa C terminus, whereas α-DB2 has a 9- fi Analysis of the peptides identi ed by LC-MS/MS revealed aa unique C terminus. Because α-catulin interacts with α-DB1 both predicted and unique components of the scaffold (Fig. 1A but not with α-DB2, we suspected that α-catulin is most likely and Table S1). The core components of the scaffold (dystrophin, recruited by association with the α-DB1 C-terminal domain. utrophin, α/β-DB, and α/β1/β2-syntrophin) were cross-identified To test this possibility, we used HEK293 cells stably expressing in each of the individual pulldowns. Our experiments identified TAP-α-DB1 or TAP-α-DB2. Coimmunoprecipitation experi- α known interactors [i.e., CASK and LIN7C with β2-syntrophin, ments revealed that TAP- -DB1 interacts with both endogenous Gα subunits with α-syntrophin (18, 19)] for each bait protein, and transiently transfected α-catulin-flag, whereas TAP-α-DB2 confirming the validity of our experimental data sets. One pro- failed to coimmunoprecipitate either protein (Fig. 2A). These tein, α-catulin (CTNNAL1) was consistently identified in the results were corroborated by experiments demonstrating that α-catulin-flag coimmunoprecipitates specifically with endoge- majority of our proteomic screens (Table S1). α α Next, we confirmed these findings using immunoprecipitation nous -DB1 but not -DB2 (Fig. 2B). Next, we used nitrocellulose blot overlay assays to test whether experiments of full-length proteins in living cells. Shown in Fig. α α α the interaction between -DB1 and -catulin is direct. TAP- 1B, lysates from HEK293 cells stably expressing TAP- 1D-ARs α-DB1, TAP-α-DB2, or untransfected HEK293 cell lysates were α α were precipitated and probed for -catulin, -DB1, and syntro- separated by SDS/PAGE, transferred to nitrocellulose, and in- phin.
Load more

Recommended publications
  • Genetic Mutations and Mechanisms in Dilated Cardiomyopathy
    Genetic mutations and mechanisms in dilated cardiomyopathy Elizabeth M. McNally, … , Jessica R. Golbus, Megan J. Puckelwartz J Clin Invest. 2013;123(1):19-26. https://doi.org/10.1172/JCI62862. Review Series Genetic mutations account for a significant percentage of cardiomyopathies, which are a leading cause of congestive heart failure. In hypertrophic cardiomyopathy (HCM), cardiac output is limited by the thickened myocardium through impaired filling and outflow. Mutations in the genes encoding the thick filament components myosin heavy chain and myosin binding protein C (MYH7 and MYBPC3) together explain 75% of inherited HCMs, leading to the observation that HCM is a disease of the sarcomere. Many mutations are “private” or rare variants, often unique to families. In contrast, dilated cardiomyopathy (DCM) is far more genetically heterogeneous, with mutations in genes encoding cytoskeletal, nucleoskeletal, mitochondrial, and calcium-handling proteins. DCM is characterized by enlarged ventricular dimensions and impaired systolic and diastolic function. Private mutations account for most DCMs, with few hotspots or recurring mutations. More than 50 single genes are linked to inherited DCM, including many genes that also link to HCM. Relatively few clinical clues guide the diagnosis of inherited DCM, but emerging evidence supports the use of genetic testing to identify those patients at risk for faster disease progression, congestive heart failure, and arrhythmia. Find the latest version: https://jci.me/62862/pdf Review series Genetic mutations and mechanisms in dilated cardiomyopathy Elizabeth M. McNally, Jessica R. Golbus, and Megan J. Puckelwartz Department of Human Genetics, University of Chicago, Chicago, Illinois, USA. Genetic mutations account for a significant percentage of cardiomyopathies, which are a leading cause of conges- tive heart failure.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • The Biomarkers of Key Mirnas and Target Genes Associated with Acute Myocardial Infarction
    The biomarkers of key miRNAs and target genes associated with acute myocardial infarction Qi Wang1, Bingyan Liu2,3, Yuanyong Wang4, Baochen Bai1, Tao Yu3 and Xian–ming Chu1,5 1 Department of Cardiology, The Affiliated hospital of Qingdao University, Qingdao, China 2 School of Basic Medicine, Qingdao University, Qingdao, China 3 Institute for Translational Medicine, Qingdao University, Qingdao, China 4 Department of Thoracic Surgery, Affiliated Hospital of Qingdao University, Qingdao, China 5 Department of Cardiology, The Affiliated Cardiovascular Hospital of Qingdao University, Qingdao, China ABSTRACT Background. Acute myocardial infarction (AMI) is considered one of the most prominent causes of death from cardiovascular disease worldwide. Knowledge of the molecular mechanisms underlying AMI remains limited. Accurate biomarkers are needed to predict the risk of AMI and would be beneficial for managing the incidence rate. The gold standard for the diagnosis of AMI, the cardiac troponin T (cTnT) assay, requires serial testing, and the timing of measurement with respect to symptoms affects the results. As attractive candidate diagnostic biomarkers in AMI, circulating microRNAs (miRNAs) are easily detectable, generally stable and tissue specific. Methods. The Gene Expression Omnibus (GEO) database was used to compare miRNA expression between AMI and control samples, and the interactions between miRNAs and mRNAs were analysed for expression and function. Furthermore, a protein-protein interaction (PPI) network was constructed. The miRNAs identified in the bioinformatic analysis were verified by RT-qPCR in an H9C2 cell line. The miRNAs in plasma samples from patients with AMI (n D 11) and healthy controls (n D 11) were used to construct Submitted 23 December 2019 receiver operating characteristic (ROC) curves to evaluate the clinical prognostic value Accepted 14 April 2020 of the identified miRNAs.
    [Show full text]
  • Integrative Analyses Identify Potential Key Genes and Pathways in Keshan
    medRxiv preprint doi: https://doi.org/10.1101/2021.03.12.21253491; this version posted March 15, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. Integrative analyses identify potential key genes and pathways in Keshan disease using whole-exome sequencing Jichang Huang1#, Chenqing Zheng2#, Rong Luo1#, Mingjiang Liu3, Qingquan Gu4, Jinshu Li5, Xiushan Wu6, Zhenglin Yang3, Xia Shen2*, Xiaoping Li3* 1 Institute of Geriatric Cardiovascular Disease, Chengdu Medical College, Chengdu, People’s Republic of China 2 State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-sen University, Guangzhou, China 3 Department of Cardiology, Hospital of the University of Electronic Science and Technology of China and Sichuan Provincial People’s Hospital, Chengdu, Sichuan, China 4 Shenzhen RealOmics (Biotech) Co., Ltd., Shenzhen, China 5 Institute of Endemic Disease, Center for Disease Control and Prevention of Sichuan Province, Chengdu, Sichuan, China 6 The Center of Heart Development, College of Life Sciences, Hunan Norma University, Changsha, China #, These authors contributed equally to this work. *, Authors for correspondence. NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice. medRxiv preprint doi: https://doi.org/10.1101/2021.03.12.21253491; this version posted March 15, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
    [Show full text]
  • 1 Supporting Information for a Microrna Network Regulates
    Supporting Information for A microRNA Network Regulates Expression and Biosynthesis of CFTR and CFTR-ΔF508 Shyam Ramachandrana,b, Philip H. Karpc, Peng Jiangc, Lynda S. Ostedgaardc, Amy E. Walza, John T. Fishere, Shaf Keshavjeeh, Kim A. Lennoxi, Ashley M. Jacobii, Scott D. Rosei, Mark A. Behlkei, Michael J. Welshb,c,d,g, Yi Xingb,c,f, Paul B. McCray Jr.a,b,c Author Affiliations: Department of Pediatricsa, Interdisciplinary Program in Geneticsb, Departments of Internal Medicinec, Molecular Physiology and Biophysicsd, Anatomy and Cell Biologye, Biomedical Engineeringf, Howard Hughes Medical Instituteg, Carver College of Medicine, University of Iowa, Iowa City, IA-52242 Division of Thoracic Surgeryh, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Canada-M5G 2C4 Integrated DNA Technologiesi, Coralville, IA-52241 To whom correspondence should be addressed: Email: [email protected] (M.J.W.); yi- [email protected] (Y.X.); Email: [email protected] (P.B.M.) This PDF file includes: Materials and Methods References Fig. S1. miR-138 regulates SIN3A in a dose-dependent and site-specific manner. Fig. S2. miR-138 regulates endogenous SIN3A protein expression. Fig. S3. miR-138 regulates endogenous CFTR protein expression in Calu-3 cells. Fig. S4. miR-138 regulates endogenous CFTR protein expression in primary human airway epithelia. Fig. S5. miR-138 regulates CFTR expression in HeLa cells. Fig. S6. miR-138 regulates CFTR expression in HEK293T cells. Fig. S7. HeLa cells exhibit CFTR channel activity. Fig. S8. miR-138 improves CFTR processing. Fig. S9. miR-138 improves CFTR-ΔF508 processing. Fig. S10. SIN3A inhibition yields partial rescue of Cl- transport in CF epithelia.
    [Show full text]
  • Disrupted Mechanobiology Links the Molecular and Cellular Phenotypes
    bioRxiv preprint doi: https://doi.org/10.1101/555391; this version posted February 21, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 Disrupted Mechanobiology Links the Molecular and Cellular 2 Phenotypes in Familial Dilated Cardiomyopathy 3 4 Sarah R. Clippinger1,2, Paige E. Cloonan1,2, Lina Greenberg1, Melanie Ernst1, W. Tom 5 Stump1, Michael J. Greenberg1,* 6 7 1 Department of Biochemistry and Molecular Biophysics, Washington University School 8 of Medicine, St. Louis, MO, 63110, USA 9 10 2 These authors contributed equally to this work 11 12 *Corresponding author: 13 Michael J. Greenberg 14 Department of Biochemistry and Molecular Biophysics 15 Washington University School of Medicine 16 660 S. Euclid Ave., Campus Box 8231 17 St. Louis, MO 63110 18 Phone: (314) 362-8670 19 Email: [email protected] 20 21 22 Running title: A DCM mutation disrupts mechanosensing 23 24 25 Keywords: Mechanosensing, stem cell derived cardiomyocytes, muscle regulation, 26 troponin, myosin, traction force microscopy 1 bioRxiv preprint doi: https://doi.org/10.1101/555391; this version posted February 21, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 27 Abstract 28 Familial dilated cardiomyopathy (DCM) is a leading cause of sudden cardiac death and a 29 major indicator for heart transplant. The disease is frequently caused by mutations of 30 sarcomeric proteins; however, it is not well understood how these molecular mutations 31 lead to alterations in cellular organization and contractility.
    [Show full text]
  • Dilated Cardiomyopathy Caused by Truncating Titin Variants
    BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any reliance Supplemental material placed on this supplemental material which has been supplied by the author(s) J Med Genet Dilated cardiomyopathy caused by truncating titin variants – Long-term outcomes, arrhythmias, response to treatment and sex differences SUPPLEMENTARY MATERIAL Christoffer Rasmus Vissing1*, MD; Torsten Bloch Rasmussen2, MD, PhD; Anne Mette Dybro2, MD; Morten Salling Olesen3,4, MSc, PhD; Lisbeth Nørum Pedersen5; MSc, PhD; Morten Jensen, MD, PhD2; Henning Bundgaard1, MD, DMSc; Alex Hørby Christensen1,6 MD, PhD 1The Capital Region’s Unit for Inherited Cardiac Diseases, Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark 2Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark 3Laboratory for Molecular Cardiology, University of Copenhagen, Copenhagen, Denmark 4Department of Biomedical Sciences, University of Copenhagen, Copenhagen, 2200 N, Denmark 5Department of Molecular Medicine, Aarhus University Hospital, Denmark. 6Department of Cardiology, Herlev-Gentofte Hospital, Copenhagen University Hospital, Copenhagen, Denmark *Corresponding author: Christoffer Rasmus Vissing, MD The Capital Region’s Unit for Inherited Cardiac Diseases, Department of Cardiology, The Heart Center, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, DK-2100 Copenhagen, Denmark, E-mail: [email protected]; Phone +45 3545 5045 1 Vissing CR, et al. J Med Genet 2020;0:1–10.
    [Show full text]
  • New Insights in RBM20 Cardiomyopathy
    Current Heart Failure Reports (2020) 17:234–246 https://doi.org/10.1007/s11897-020-00475-x TRANSLATIONAL RESEARCH IN HEART FAILURE (J BACKS & M VAN DEN HOOGENHOF, SECTION EDITORS) New Insights in RBM20 Cardiomyopathy D. Lennermann1,2 & J. Backs1,2 & M. M. G. van den Hoogenhof1,2 Published online: 13 August 2020 # The Author(s) 2020 Abstract Purpose of Review This review aims to give an update on recent findings related to the cardiac splicing factor RNA-binding motif protein 20 (RBM20) and RBM20 cardiomyopathy, a form of dilated cardiomyopathy caused by mutations in RBM20. Recent Findings While most research on RBM20 splicing targets has focused on titin (TTN), multiple studies over the last years have shown that other splicing targets of RBM20 including Ca2+/calmodulin-dependent kinase IIδ (CAMK2D) might be critically involved in the development of RBM20 cardiomyopathy. In this regard, loss of RBM20 causes an abnormal intracellular calcium handling, which may relate to the arrhythmogenic presentation of RBM20 cardiomyopathy. In addition, RBM20 presents clinically in a highly gender-specific manner, with male patients suffering from an earlier disease onset and a more severe disease progression. Summary Further research on RBM20, and treatment of RBM20 cardiomyopathy, will need to consider both the multitude and relative contribution of the different splicing targets and related pathways, as well as gender differences. Keywords RBM20 . Dilated cardiomyopathy . CaMKIIδ . Calcium handling . Gender differences . Titin Introduction (ARVC), where a small number of genes account for most of the genetic causes, DCM-causing mutations have been ob- Dilated cardiomyopathy (DCM), as defined by left ventricular served in a variety of genes of diverse ontology [2].
    [Show full text]
  • Individual Protomers of a G Protein-Coupled Receptor Dimer Integrate Distinct Functional Modules
    OPEN Citation: Cell Discovery (2015) 1, 15011; doi:10.1038/celldisc.2015.11 © 2015 SIBS, CAS All rights reserved 2056-5968/15 ARTICLE www.nature.com/celldisc Individual protomers of a G protein-coupled receptor dimer integrate distinct functional modules Nathan D Camp1, Kyung-Soon Lee2, Jennifer L Wacker-Mhyre2, Timothy S Kountz2, Ji-Min Park2, Dorathy-Ann Harris2, Marianne Estrada2, Aaron Stewart2, Alejandro Wolf-Yadlin1, Chris Hague2 1Department of Genome Sciences, University of Washington School of Medicine, Seattle, WA, USA; 2Department of Pharmacology, University of Washington School of Medicine, Seattle, WA, USA Recent advances in proteomic technology reveal G-protein-coupled receptors (GPCRs) are organized as large, macromolecular protein complexes in cell membranes, adding a new layer of intricacy to GPCR signaling. We previously reported the α1D-adrenergic receptor (ADRA1D)—a key regulator of cardiovascular, urinary and CNS function—binds the syntrophin family of PDZ domain proteins (SNTA, SNTB1, and SNTB2) through a C-terminal PDZ ligand inter- action, ensuring receptor plasma membrane localization and G-protein coupling. To assess the uniqueness of this novel GPCR complex, 23 human GPCRs containing Type I PDZ ligands were subjected to TAP/MS proteomic analysis. Syntrophins did not interact with any other GPCRs. Unexpectedly, a second PDZ domain protein, scribble (SCRIB), was detected in ADRA1D complexes. Biochemical, proteomic, and dynamic mass redistribution analyses indicate syntrophins and SCRIB compete for the PDZ ligand, simultaneously exist within an ADRA1D multimer, and impart divergent pharmacological properties to the complex. Our results reveal an unprecedented modular dimeric architecture for the ADRA1D in the cell membrane, providing unexpected opportunities for fine-tuning receptor function through novel protein interactions in vivo, and for intervening in signal transduction with small molecules that can stabilize or disrupt unique GPCR:PDZ protein interfaces.
    [Show full text]
  • The Amino Acid Sequence of Troponin C from Chicken Skeletal Muscle
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Volume 70, number 1 FEBS LETTERS November 1976 THE AMINO ACID SEQUENCE OF TROPONIN C FROM CHICKEN SKELETAL MUSCLE J. M. WILKINSON Department of Biochemistry, University of Birmingham, P. 0. Box 363, Birmingham, BI5 2TT. England Received 21 September 1976 1. Introduction Hirabayshi and Perry [5] have shown that chicken troponin C isolated from a mixture of breast and leg Troponin C is the component of the troponin muscle is a single antigen and hence, by inference the complex which binds Ca2+ and thereby triggers the troponin C components present in both tissues are activation of the actomyosin ATPase and hence the very similar if not identical. The present paper reports onset of contraction. The amino acid sequence of the amino acid sequence of chicken troponin C and troponin C from rabbit fast skeletal muscle has been discusses its relationship with rabbit troponin C to determined by Collins et al. [l ] and that from which it is very similar. No evidence of heterogeneity bovine cardiac muscle by van Eerd and Takahashi in the sequence has been found. [2]. These proteins have been shown to be homolo- gous not only with the calcium binding parvalbumins 2. Experimental but also with both the DTNB and alkali light chains of myosin [a]. Based on the homology with the Troponin C was prepared from mixed breast and parvalbumins, four binding sites for Ca2+ have been leg muscle and purified by chromatography on DEAE- proposed for rabbit troponin C and a three dimensio- cellulose as described by Perry and Cole 171.
    [Show full text]
  • Supplementary Table 1
    Supplementary Table 1. Large-scale quantitative phosphoproteomic profiling was performed on paired vehicle- and hormone-treated mTAL-enriched suspensions (n=3). A total of 654 unique phosphopeptides corresponding to 374 unique phosphoproteins were identified. The peptide sequence, phosphorylation site(s), and the corresponding protein name, gene symbol, and RefSeq Accession number are reported for each phosphopeptide identified in any one of three experimental pairs. For those 414 phosphopeptides that could be quantified in all three experimental pairs, the mean Hormone:Vehicle abundance ratio and corresponding standard error are also reported. Peptide Sequence column: * = phosphorylated residue Site(s) column: ^ = ambiguously assigned phosphorylation site Log2(H/V) Mean and SE columns: H = hormone-treated, V = vehicle-treated, n/a = peptide not observable in all 3 experimental pairs Sig. column: * = significantly changed Log 2(H/V), p<0.05 Log (H/V) Log (H/V) # Gene Symbol Protein Name Refseq Accession Peptide Sequence Site(s) 2 2 Sig. Mean SE 1 Aak1 AP2-associated protein kinase 1 NP_001166921 VGSLT*PPSS*PK T622^, S626^ 0.24 0.95 PREDICTED: ATP-binding cassette, sub-family A 2 Abca12 (ABC1), member 12 XP_237242 GLVQVLS*FFSQVQQQR S251^ 1.24 2.13 3 Abcc10 multidrug resistance-associated protein 7 NP_001101671 LMT*ELLS*GIRVLK T464, S468 -2.68 2.48 4 Abcf1 ATP-binding cassette sub-family F member 1 NP_001103353 QLSVPAS*DEEDEVPVPVPR S109 n/a n/a 5 Ablim1 actin-binding LIM protein 1 NP_001037859 PGSSIPGS*PGHTIYAK S51 -3.55 1.81 6 Ablim1 actin-binding
    [Show full text]
  • Viewed and Published Immediately Upon Acceptance Cited in Pubmed and Archived on Pubmed Central Yours — You Keep the Copyright
    BMC Genomics BioMed Central Research article Open Access Differential gene expression in ADAM10 and mutant ADAM10 transgenic mice Claudia Prinzen1, Dietrich Trümbach2, Wolfgang Wurst2, Kristina Endres1, Rolf Postina1 and Falk Fahrenholz*1 Address: 1Johannes Gutenberg-University, Institute of Biochemistry, Mainz, Johann-Joachim-Becherweg 30, 55128 Mainz, Germany and 2Helmholtz Zentrum München – German Research Center for Environmental Health, Institute for Developmental Genetics, Ingolstädter Landstraße 1, 85764 Neuherberg, Germany Email: Claudia Prinzen - [email protected]; Dietrich Trümbach - [email protected]; Wolfgang Wurst - [email protected]; Kristina Endres - [email protected]; Rolf Postina - [email protected]; Falk Fahrenholz* - [email protected] * Corresponding author Published: 5 February 2009 Received: 19 June 2008 Accepted: 5 February 2009 BMC Genomics 2009, 10:66 doi:10.1186/1471-2164-10-66 This article is available from: http://www.biomedcentral.com/1471-2164/10/66 © 2009 Prinzen et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Background: In a transgenic mouse model of Alzheimer disease (AD), cleavage of the amyloid precursor protein (APP) by the α-secretase ADAM10 prevented amyloid plaque formation, and alleviated cognitive deficits. Furthermore, ADAM10 overexpression increased the cortical synaptogenesis. These results suggest that upregulation of ADAM10 in the brain has beneficial effects on AD pathology. Results: To assess the influence of ADAM10 on the gene expression profile in the brain, we performed a microarray analysis using RNA isolated from brains of five months old mice overexpressing either the α-secretase ADAM10, or a dominant-negative mutant (dn) of this enzyme.
    [Show full text]